1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Dendritic Cell based p53 Vaccine: new trials by email Literature Review of Dendritic Cell based p53 Vaccine trials Research Report on Dendritic Cell based p53 Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) Nivolumab, Ipilimumab, Dendritic Cell based p53 Vaccine - Small Cell Lung Cancer, Lung Cancer | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 14 | 2018-03-15 | 2023-03-30 |
Lung Diseases (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
United States (1)